Article
Panniculitis during Dasatinib Therapy for Imatinib-Resistant Chronic Myelogenous Leukemia
14 Jun 2006
Abstract excerpt
To the Editor: We describe two cases of panniculitis apparently caused by dasatinib. In one, management after the diagnosis of the panniculitis allowed dasatinib therapy to be continued. In the first case, a 55-year-old woman (Patient 1) presented in the chronic phase of chronic myelogenous leukemia (CML) and did not have a major cytogenetic response (defined by the presence of the Philadelphia chromosome in <35...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
